Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study

BACKGROUND: Live-attenuated influenza vaccines (LAIVs) are not licensed in children younger than 2 years of age because of a wheezing safety signal that has not been fully elucidated. In 2000, the Kaiser Permanente Vaccine Study Center conducted a placebo-controlled randomized clinical trial (RCT) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxter, Roger P., Lewis, Ned, Fireman, Bruce, Hansen, John, Klein, Nicola P., Ortiz, Justin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Williams & Wilkins 2018
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847407/
https://www.ncbi.nlm.nih.gov/pubmed/28914750
http://dx.doi.org/10.1097/INF.0000000000001783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847407/
https://www.ncbi.nlm.nih.gov/pubmed/28914750
http://dx.doi.org/10.1097/INF.0000000000001783

Ejemplares similares